Emerging clinical concerns in the ageing haemophilia patient
Barbara A. Konkle(University of Washington), Bruce M. Ewenstein(CSL (United States)), Craig M. Kessler(Georgetown University), Louis M. Aledort(Icahn School of Medicine at Mount Sinai), Anaadriana Zakarija(Northwestern University), Jens Christian Andersen(The Barbara Ann Karmanos Cancer Institute), Doris Quon(Orthopaedic Hospital), Peter A. Kouides(Unity Health System), Patrick F. Fogarty(Pfizer (United States)), Margaret V. Ragni(University of Pittsburgh Medical Center)
Cited by 68
Related Papers
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2003|809
Definitions in Hemophilia
|Thrombosis and Haemostasis|2001|772